Retatrutide is a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://haleemaeftn786367.collectblogs.com/80873327/tirzepatide-a-promising-new-treatment-for-obesity